These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 37238943)

  • 41. Fecal microbiota transplantation protects rotenone-induced Parkinson's disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis.
    Zhao Z; Ning J; Bao XQ; Shang M; Ma J; Li G; Zhang D
    Microbiome; 2021 Nov; 9(1):226. PubMed ID: 34784980
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gut microbiota and hepatic encephalopathy.
    Dhiman RK
    Metab Brain Dis; 2013 Jun; 28(2):321-6. PubMed ID: 23463489
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Targeting the gut microbiome in the management of sepsis-associated encephalopathy.
    Barlow B; Ponnaluri S; Barlow A; Roth W
    Front Neurol; 2022; 13():999035. PubMed ID: 36247756
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gut Microbiome as a Possible Cause of Occurrence and Therapeutic Target in Chronic Obstructive Pulmonary Disease.
    Lim EY; Song EJ; Shin HS
    J Microbiol Biotechnol; 2023 Sep; 33(9):1111-1118. PubMed ID: 37164760
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Restoration of dysbiotic human gut microbiome for homeostasis.
    Dixit K; Chaudhari D; Dhotre D; Shouche Y; Saroj S
    Life Sci; 2021 Aug; 278():119622. PubMed ID: 34015282
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Impact of Gut Microbiota on Radiation-Induced Enteritis.
    Jian Y; Zhang D; Liu M; Wang Y; Xu ZX
    Front Cell Infect Microbiol; 2021; 11():586392. PubMed ID: 34395308
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gut Microbiota Disorder, Gut Epithelial and Blood-Brain Barrier Dysfunctions in Etiopathogenesis of Dementia: Molecular Mechanisms and Signaling Pathways.
    Welcome MO
    Neuromolecular Med; 2019 Sep; 21(3):205-226. PubMed ID: 31115795
    [TBL] [Abstract][Full Text] [Related]  

  • 48. New Therapeutic Drugs from Bioactive Natural Molecules: The Role of Gut Microbiota Metabolism in Neurodegenerative Diseases.
    Di Meo F; Donato S; Di Pardo A; Maglione V; Filosa S; Crispi S
    Curr Drug Metab; 2018; 19(6):478-489. PubMed ID: 29623833
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Crosstalk between Gut and Brain in Alzheimer's Disease: The Role of Gut Microbiota Modulation Strategies.
    Shabbir U; Arshad MS; Sameen A; Oh DH
    Nutrients; 2021 Feb; 13(2):. PubMed ID: 33669988
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synbiotics, prebiotics and probiotics for solid organ transplant recipients.
    Cooper TE; Scholes-Robertson N; Craig JC; Hawley CM; Howell M; Johnson DW; Teixeira-Pinto A; Jaure A; Wong G
    Cochrane Database Syst Rev; 2022 Sep; 9(9):CD014804. PubMed ID: 36126902
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gut Microbiota and Neuroinflammation in Acute Liver Failure and Chronic Liver Disease.
    Giuli L; Maestri M; Santopaolo F; Pompili M; Ponziani FR
    Metabolites; 2023 Jun; 13(6):. PubMed ID: 37367929
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gut Dysbiosis and Kidney Diseases.
    Cao C; Zhu H; Yao Y; Zeng R
    Front Med (Lausanne); 2022; 9():829349. PubMed ID: 35308555
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antibiotic-induced microbiome depletion in adult mice disrupts blood-brain barrier and facilitates brain infiltration of monocytes after bone-marrow transplantation.
    Sun N; Hu H; Wang F; Li L; Zhu W; Shen Y; Xiu J; Xu Q
    Brain Behav Immun; 2021 Feb; 92():102-114. PubMed ID: 33242652
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gut dysbiosis and age-related neurological diseases; an innovative approach for therapeutic interventions.
    Holmes A; Finger C; Morales-Scheihing D; Lee J; McCullough LD
    Transl Res; 2020 Dec; 226():39-56. PubMed ID: 32755639
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anorexia nervosa and gut microbiome: implications for weight change and novel treatments.
    Wei Y; Peng S; Lian C; Kang Q; Chen J
    Expert Rev Gastroenterol Hepatol; 2022 Apr; 16(4):321-332. PubMed ID: 35303781
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nutritional and therapeutic approaches for protecting human gut microbiota from psychotropic treatments.
    Ait Chait Y; Mottawea W; Tompkins TA; Hammami R
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jun; 108():110182. PubMed ID: 33232785
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dysbiosis and Alzheimer's disease: role of probiotics, prebiotics and synbiotics.
    Thakkar A; Vora A; Kaur G; Akhtar J
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Nov; 396(11):2911-2923. PubMed ID: 37284896
    [TBL] [Abstract][Full Text] [Related]  

  • 58. POTENTIAL THERAPEUTIC OPTIONS TARGETING THE GUT DYSBIOSIS IN CHRONIC KIDNEY DISEASE.
    Dobrek Ł
    Wiad Lek; 2022; 75(7):1757-1764. PubMed ID: 35962694
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association of Enteric Protist Blastocystis spp. and Gut Microbiota with Hepatic Encephalopathy.
    Yildiz S; Doğan İ; Doğruman-Al F; Nalbantoğlu U; Üstek D; Sarzhanov F; Yildirim S
    J Gastrointestin Liver Dis; 2016 Dec; 25(4):489-497. PubMed ID: 27981305
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Role of Gut Microbiota in Blood-Brain Barrier Disruption after Stroke.
    Zeng M; Peng M; Liang J; Sun H
    Mol Neurobiol; 2023 Jul; ():. PubMed ID: 37498481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.